Neutrophils Are Resistant to Yersinia YopJ/P-Induced Apoptosis and Are Protected from ROS-Mediated Cell Death by the Type III Secretion System

Justin L. Spinner, Keun Seok Seo, Jason L. O'Loughlin et al. · 2010

Read Neutrophils Are Resistant to Yersinia YopJ/P-Induced Apoptosis and Are Protected from ROS-Mediated Cell Death by the Type III Secretion System by Justin L. Spinner, Keun Seok Seo, Jason L. O'Loughlin et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009279.txt.

Introduction

Justin Spinner and co-authors published this infection study in PLOS ONE in 2010. The body's first defense against bacteria pairs macrophages with neutrophils, fast-acting white blood cells. Yersinia bacteria, which include the plague germ, slip past that defense. They inject proteins into immune cells to disable them.

One injected protein, YopJ/P, can push cells into programmed death. The team found that neutrophils resist that death signal. The bacteria's own injection system also shields neutrophils from death by reactive oxygen. Knowing which immune cells refuse to die helps explain how the body keeps fighting Yersinia.

Catalog record

CREATORJustin L. Spinner, Keun Seok Seo, Jason L. O'Loughlin et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009279

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Neutrophils Are Resistant to Yersinia YopJ/P-Induced Apoptosis and Are Protected from ROS-Mediated Cell Death by the Type III Secretion System Authors: Justin L. Spinner, Keun Seok Seo, Jason L. O'Loughlin, Jennifer A. Cundiff, Scott A. Minnich, Gregory A. Bohach, Scott D. Kobayashi Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0009279 ABSTRACT The human innate immune system relies on the coordinated activity of macrophages and polymorphonuclear leukocytes (neutrophils or PMNs) for defense against bacterial pathogens. Yersinia spp. subvert the innate immune response to cause disease in humans. In particular, the Yersinia outer protein YopJ ( Y. pestis and Y. pseudotuberculosis ) and YopP ( Y. enterocolitica ) rapidly induce apoptosis in murine macrophages and dendritic cells. However, the effects of Yersinia Yop J/P on neutrophil fate are not clearly defined. In this study, we utilized wild-type and mutant strains of Yersinia to test the contribution of YopJ and YopP on induction of apoptosis in human monocyte-derived macrophages (HMDM) and neutrophils. Whereas YopJ and YopP similarly induced apoptosis in HMDMs, interaction of human neutrophils with virulence plasmid-containing Yersinia did not result in PMN caspase activation, release of LDH, or loss of membrane integrity greater than PMN controls. In contrast, interaction of human PMNs with the virulence plasmid-deficient Y. pestis strain KIM6 resulted in increased surface exposure of phosphatidylserine (PS) and cell death. PMN reactive oxygen species (ROS) production was inhibited in a virulence plasmid-dependent but YopJ/YopP-independent manner. Following phagocytic interaction with Y. pestis strain KIM6, inhibition of PMN ROS production with diphenyleneiodonium chloride resulted in a reduction of PMN cell death similar to that induced by the virulence plasmid-containing strain Y. pestis KIM5. Our findings showed that Yersinia YopJ and/or YopP did not induce pronounced apoptosis in human neutrophils. Furthermore, robust PMN ROS production in response to virulence plasmid-deficient Yersinia was associated with increased PMN cell death, suggesting that Yersinia inhibition of PMN ROS production plays a role in evasion of the human innate immune response in part by limiting PMN apoptosis. INTRODUCTION The cellular arm of the human innate immune system includes the myeloid progenitor-derived mononuclear and polymorphonuclear phagocytes, which recognize and eliminate a diverse array of bacterial pathogens. The mononuclear phagocytes (monocytes, macrophages and dendritic cells) produce proinflammatory cytokines and are capable of presenting antigen to CD4+ T cells via class II MHC [1] . Polymorphonuclear leukocytes (neutrophils or PMNs) are the most abundant circulating leukocyte and essential for removal of pathogens [2] . PMNs are recruited to sites of infection and rapidly phagocytose invading microbes. Following phagocytosis, PMNs destroy pathogens by releasing highly microbicidal NADPH oxidase-derived reactive oxygen species (ROS) and a broad array of potent antimicrobial components into the pathogen-containing vacuoles [2] . Uptake of bacteria induces a form of PMN cell death termed phagocytosis-induced cell death (PICD) that is dependent upon ROS production and is important for resolution of infection and inflammation [3] – [8] . Macrophage clearance of apoptotic PMNs prevents release of cytotoxic granule components and limits subsequent damage to surrounding healthy tissues [2] , [4] , [6] – [8] . Overall, the innate immune system is highly efficient and essential for human health and subversion of the innate immune system is linked to increased bacterial pathogenicity [9] . The genus Yersinia contains three species pathogenic for humans and rodents ( Y. enterocolitica , Y. pseudotuberculosis , and Y. pestis ). Y. enterocolitica and Y. pseudotuberculosis are transmitted by fecal-oral route and cause gastrointestinal syndromes, lymphadenitis, and septicemia [10] . Y. pestis is typically transmitted through the bite of an infected flea and causes bubonic and/or septicemic plague [11] . Alternatively, a rare but highly lethal pneumonic form of plague may result following inhalation of aerosolized droplets containing Y. pestis [11] . Despite epidemiologic differences, Yersinia pathogenesis is dependent upon the presence of a homologous virulence plasmid termed pCD1 in Y. pestis and pYV in Y. enterocolitica and Y. pseudotuberculosis . The Yersinia virulence plasmid encodes a type III secretion system (TTSS) and 6 known effector proteins termed Yersinia outer proteins (Yops) [11] . In vivo , Y. pestis injects Yops into host immune cells with a preference for dendritic cells, macrophages, and PMNs [12] . Once within the cell, the Yop proteins cooperatively interfere with host cell signal transduction pathways [13] . In particular, the effector protein YopJ (YopP in Y. enterocolitica ) has been shown to be an acetyltransferase [14] – [16] , a deubiquitinating cysteine protease [17] , [18] , and required for cleavage of the caspase-8 substrate BID [19] . Yersinia YopJ and YopP have been shown to rapidly activate programmed cell death (apoptosis) in macrophages and dendritic cells, but not human epithelial cells [19] – [27] . Sequence polymorphisms in the N-terminus of the YopJ/YopP proteins result in higher host cell translocation efficiency of YopP compared to YopJ [28] , [29] . The increased delivery of YopP results in increased J774A.1 macrophage and dendritic cell death [28] , [29] . Increased host cell cytotoxicity attenuates Yersinia infection in mice [28] , [30] , indicating that a controlled level of immune cell apoptosis is required for Yersinia virulence. However, Y. pestis induction of apoptosis in human PMNs and human monocyte-derived macrophages (HMDMs) has not been investigated directly. Thus, we evaluated human PMN and HMDM cell fate following incubation with Yersinia expressing YopJ or YopP. Our findings show that YopP and (to a lesser extent) YopJ are cytotoxic to HMDMs but not human PMNs. Furthermore, Yersinia TTSS-dependent inhibition of human PMN ROS production is associated with reduced PMN apoptosis. Reduction of PMN apoptosis potentially delays the acute inflammatory response and facilitates Yersinia persistence via intracellular and extracellular survival [31] , [32] at the site of infection. MATERIALS AND METHODS Human monocytes and PMNs were isolated from heparinized venous blood of healthy donors in accordance with a protocol approved by the University of Idaho Institutional Review Board for Human Subjects (approval number 05-056). Donors were informed of the procedure risks and provided written consent prior to enrollment. MACROPHAGE AND PMN CELL ISOLATION AND CULTURE The murine macrophage-like cell line J774A.1 cells were cultured at 37°C under 5% CO 2 in Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA), 100 U/ml penicillin, 100 µg/mL streptomycin, and 2 mM L-glutamine (Invitrogen). For HMDM isolation, freshly isolated heparinized human blood was underlaid with an equal volume of Ficoll-Paque PLUS (Amersham Biosciences, Piscataway, NJ), and centrifuged at 485×g for 25 min. The buffy coat layer was removed by aspiration and diluted with Dulbecco's Phosphate Buffered Saline (DPBS; Invitrogen). The mixture was centrifuged for 25 min at 216×g and the cell pellet suspended in RPMI medium 1640 (Invitrogen) supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/mL streptomycin, and 2 mM L-glutamine (Invitrogen). Cells were allowed to adhere and differentiate for 4–6 days at 37°C under 5% CO 2 in tissue culture flasks. HMDM purity was determined by staining with CD14 and CD68 antibodies conjugated to phycoerythrin (Invitrogen) and analysis by flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA) as described previously [33] . HMDM preparations routinely contained 90%–97% HMDMs. Human PMN isolation was performed as described previously [32] . PMNs were isolated fresh the day of

Read the complete text